𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative Prediction of Human Intestinal Glucuronidation Effects on Intestinal Availability of UDP-Glucuronosyltransferase Substrates Using In Vitro Data

✍ Scribed by Nakamori, F.; Naritomi, Y.; Hosoya, K.-i.; Moriguchi, H.; Tetsuka, K.; Furukawa, T.; Kadono, K.; Yamano, K.; Terashita, S.; Teramura, T.

Book ID
118144255
Publisher
American Society for Pharmacology and Experimental Therapeutics
Year
2012
Tongue
English
Weight
357 KB
Volume
40
Category
Article
ISSN
0090-9556

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Assessment of presystemic and systemic i
Assessment of presystemic and systemic intestinal availability of orally administered drugs using in vitro and in vivo data in humans: Intestinal sulfation metabolism impacts presystemic availability much more than systemic availability of salbutamol, SULT1A3 substrate
✍ Takashi Mizuma πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

Although hepatic availability has been extensively studied to assess the oral bioavailability of drugs, intestinal availability has not, especially that related to conjugative metabolism (phase II metabolism). The present study assessed intestinal presystemic availability by integrating the reported

In vitro inhibitory effects of non-stero
In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9β€”potent inhibition by niflumic acid
✍ Yuji Mano; Takashi Usui; Hidetaka Kamimura πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

The inhibitory potencies of non-steroidal anti-inflammatory drugs (NSAIDs) on UDP-glucuronosyltransferase (UGT) 1A9 activity were investigated in recombinant human UGT1A9 using 4-methylumbelliferone (4-MU) as a substrate for glucuronidation. 4-MU glucuronidation (4-MUG) showed Michaelis-Menten kinet